159 related articles for article (PubMed ID: 20599787)
1. Human B-type natriuretic peptide is not degraded by meprin A.
Dickey DM; Potter LR
Biochem Pharmacol; 2010 Oct; 80(7):1007-11. PubMed ID: 20599787
[TBL] [Abstract][Full Text] [Related]
2. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.
Pankow K; Wang Y; Gembardt F; Krause E; Sun X; Krause G; Schultheiss HP; Siems WE; Walther T
Circ Res; 2007 Oct; 101(9):875-82. PubMed ID: 17823376
[TBL] [Abstract][Full Text] [Related]
3. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
Dickey DM; Potter LR
J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.
Boerrigter G; Costello-Boerrigter LC; Harty GJ; Huntley BK; Cataliotti A; Lapp H; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1744-50. PubMed ID: 19386989
[TBL] [Abstract][Full Text] [Related]
5. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
Semenov AG; Katrukha AG
Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
[TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
Lainchbury JG; Richards AM; Nicholls MG; Espiner EA; Yandle TG
J Clin Endocrinol Metab; 1999 Feb; 84(2):723-9. PubMed ID: 10022444
[TBL] [Abstract][Full Text] [Related]
7. Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge?
Lippi G; Sanchis-Gomar F
Int J Cardiol; 2016 Sep; 219():111-4. PubMed ID: 27317994
[TBL] [Abstract][Full Text] [Related]
8. Metalloendopeptidases of the mouse kidney brush border: meprin and endopeptidase-24.11.
Bond JS; Butler PE; Beynon RJ
Biomed Biochim Acta; 1986; 45(11-12):1515-21. PubMed ID: 3555473
[TBL] [Abstract][Full Text] [Related]
9. The hydrolysis of brain and atrial natriuretic peptides by porcine choroid plexus is attributable to endopeptidase-24.11.
Bourne A; Kenny AJ
Biochem J; 1990 Oct; 271(2):381-5. PubMed ID: 2146950
[TBL] [Abstract][Full Text] [Related]
10. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form.
Brandt I; Lambeir AM; Ketelslegers JM; Vanderheyden M; Scharpé S; De Meester I
Clin Chem; 2006 Jan; 52(1):82-7. PubMed ID: 16254193
[TBL] [Abstract][Full Text] [Related]
12. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma.
Belenky A; Smith A; Zhang B; Lin S; Despres N; Wu AH; Bluestein BI
Clin Chim Acta; 2004 Feb; 340(1-2):163-72. PubMed ID: 14734208
[TBL] [Abstract][Full Text] [Related]
13. Purification of meprin from human kidney and its role in parathyroid hormone degradation.
Yamaguchi T; Fukase M; Sugimoto T; Kido H; Chihara K
Biol Chem Hoppe Seyler; 1994 Dec; 375(12):821-4. PubMed ID: 7710697
[TBL] [Abstract][Full Text] [Related]
14. Detection of Neprilysin-Derived BNP Fragments in the Circulation: Possible Insights for Targeted Neprilysin Inhibition Therapy for Heart Failure.
Feygina EE; Artemieva MM; Postnikov AB; Tamm NN; Bloshchitsyna MN; Medvedeva NA; Katrukha AG; Semenov AG
Clin Chem; 2019 Oct; 65(10):1239-1247. PubMed ID: 31307994
[TBL] [Abstract][Full Text] [Related]
15. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
[TBL] [Abstract][Full Text] [Related]
16. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
Kishimoto I; Hamra FK; Garbers DL
Can J Physiol Pharmacol; 2001 Aug; 79(8):715-22. PubMed ID: 11558680
[TBL] [Abstract][Full Text] [Related]
17. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat.
Kirk JE; Wilkins MR
Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896
[TBL] [Abstract][Full Text] [Related]
18. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Januzzi JL; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Cohen-Solal A; Richards AM; Launay JM; Mebazaa A;
JACC Heart Fail; 2015 Aug; 3(8):629-36. PubMed ID: 26251090
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of a carboxy-terminal fragment of parathyroid hormone-related protein by rat kidney: evidence for a crucial role of meprin.
Yamaguchi T; Fukase M; Sugimoto T; Chihara K
Horm Metab Res; 1995 Mar; 27(3):131-6. PubMed ID: 7607602
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
